Skip to main content

Bahrain approves Chinese COVID-19 vaccine for front-line workers

The experimental vaccine is currently in phase III clinical trials.
A picture shows the Manama's repurposed convention centre, in which 6,000 people are participating in a large-scale trial of a Chinese-sponsored vaccine for the Covid-19 coronavirus, on August 27, 2020 in the Bahraini capital. - Chinese drug giant Sinopharm began testing the inactivated COVID-19 jab in Bahrain earlier this month after starting a similar trial on 15,000 subjects in the nearby United Arab Emirates in July. The current phase of the study, in which the vaccine's efficacy and safety is tested in

Bahrain’s Health Ministry has approved a coronavirus vaccine for emergency use on front-line health workers, the state news agency BNA reported Tuesday. 

"The results of Phase I and Phase II clinical trials showed the vaccine is safe and effective," Bahrain's Health Minister Faeqa bint Saeed Al Saleh said on Tuesday, according to Reuters. 

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.


Only $100 per year.